The role of artificial intelligence in pharmacy: Revolutionizing drug development and beyond

Abstract Artificial intelligence (AI) is revolutionizing drug development by expediting the discovery, formulation, and testing of potential treatments. By analyzing vast datasets, such as genetic information, AI algorithms pinpoint disease targets and predict drug interactions, accelerating the entire process. This reduces reliance on extensive animal testing, leading to faster development and potentially higher approval rates. AI optimizes costs by streamlining research, predicting drug behavior, and designing better experiments, reducing the need for costly animal testing. Moreover, AI analyzes real‐world patient data to personalize drug treatments, potentially improving adherence and outcomes. This comprehensive overview of AI in drug development covers discovery, delivery, dosage form design, process optimization, testing, and pharmacokinetic/pharmacodynamic investigations. It assesses the strengths and weaknesses of AI techniques in pharmaceutical technology while acknowledging potential limitations. The pursuit of more potent and stable drugs to address unmet medical needs is a key goal. However, addressing concerns over toxicity necessitates further investigation. Developing therapeutic molecules with optimal properties for healthcare use remains a priority. Yet, the pharmacy sector faces challenges requiring further development through technology‐driven approaches to meet global medical and healthcare demands. This review aims to discuss the role of AI in the field of pharmacy.